Final report of phase 1 study of the DOT1L inhibitor, pinometostat (EPZ-5676), in children with relapsed or refractory MLL-r acute leukemia Meeting Abstract
| Authors: | Shukla, N.; Wetmore, C.; O'Brien, M. M.; Silverman, L. B.; Brown, P.; Cooper, T. M.; Thomson, B.; Blakemore, S. J.; Daigle, S.; Ben, Suttle; Waters, N. J.; Krivstov, A. V.; Armstrong, S. A.; Ho, P. T.; Gore, L. |
| Abstract Title: | Final report of phase 1 study of the DOT1L inhibitor, pinometostat (EPZ-5676), in children with relapsed or refractory MLL-r acute leukemia |
| Meeting Title: | 58th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 128 |
| Issue: | 22 |
| Meeting Dates: | 2016 Dec 3-6 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2016-12-02 |
| Language: | English |
| ACCESSION: | WOS:000394452304097 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V128.22.2780.2780 |
| Notes: | Meeting Abstract: 2780 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work